MAPK1 and colorectal carcinoma: In support of this notion, our biochemical analyses using a specific peptide inhibitor, siRNA and CRISPR knockout demonstrated that inhibition or loss of PTPRS resulted in elevated ERK phosphorylation in both mutant KRAS and wild-type KRAS CRC cell lines (Fig. 2).